TheProfitWatch

MRUS - Merus N.V. Common Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
94.9 0.05 (0.05%) --- --- --- 0.0 (0.0%) 0.05 (0.05%) --- 0.0 (0.0%)

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-2.23
Diluted EPS:
-2.23
Basic P/E:
-42.5785
Diluted P/E:
-42.5785
RSI(14) 1m:
54.55
VWAP:
94.95
RVol:
0.5616

Events

Period Kind Movement Occurred At

Related News